Home > Healthcare > Pharmaceuticals > Drug Delivery > Nanotechnology-based Drug Delivery Market

Nanotechnology-based Drug Delivery Market Size

Report ID: GMI6208
Published Date: Jul 2023
Report Format: PDF

Download Free Sample

Nanotechnology-based Drug Delivery Market Size

Nanotechnology-based Drug Delivery Market size accounted for USD 95.2 billion in 2022 and is estimated to grow at a CAGR of 12.6% to reach USD 308.4 billion by end of 2032. The growing preference for precision medicines is one of the significant growth drivers for the nanotechnology-based drug delivery industry.

To get key market trends

Download Free Sample

As individuals have unique genetic makeup and varying responses to treatments, there is a rising demand for tailored therapeutic solutions. Therefore, nanotechnology-based drug delivery systems offer the ability to customize treatments based on specific patient characteristics. Also, by modifying nanoparticle properties, such as targeting ligands, size, and surface charge, personalized medicines can be developed to optimize treatment outcomes.

Nanotechnology-based drug delivery refers to the application of nanoscale materials and technologies in designing and developing systems for the targeted delivery of therapeutic agents, such as drugs, genes, or vaccines, to specific sites within the body.

Nanotechnology-based Drug Delivery Market Report Attributes
Report Attribute	Details
Base Year:	2022
Nanotechnology-based Drug Delivery Market Size in 2022:	USD 95.2 Billion
Forecast Period:	2023 to 2032
Forecast Period 2023 to 2032 CAGR:	12.6%
2032 Value Projection:	USD 308.4 Billion
Historical Data for:	2018 to 2022
No. of Pages:	110
Tables, Charts & Figures:	156
Segments covered:	Technology, Application, and Region
Growth Drivers:	Growing prevalence of chronic conditions Increasing preference for personalized medicines Increasing advancements in nanomaterials
Pitfalls & Challenges:	Stringent regulatory policies High cost of nanotechnology drug delivery technique

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for nanotechnology-based drug delivery accounted for USD 95.2 billion in 2022 and is estimated to grow at a CAGR of 12.6% through 2032, owing to the growing preference for precision medicines.

Nanoparticles technology segment will grow at 12.4% CAGR through 2032. Continuous advancements in nanomaterials have led to the development of a diverse range of nanoparticle platforms, thereby offering flexibility and versatility in drug delivery applications.

North America market for nanotechnology-based drug delivery accounted for 46.6% revenue share in 2022 and will grow at considerable rate in the coming years, backed by the increasing prevalence of chronic diseases, a high disposable income, and robust healthcare infrastructure.

AbbVie Inc., BlueWillow Biologics Inc., Camurus AB, Celgene, Inc., Cristal Therapeutics, EyePoint Pharmaceuticals, and Johnson and Johnson, among others.